September 2024 in “Health Problems of Civilization” This study describes the efficacy of oral isotretinoin in treating severe, hormonal, and treatment-resistant acne, noting significant side effects that depend on dose and duration, including teratogenic risks and common issues like skin dryness, while underscoring the importance of systematic monitoring to mitigate adverse effects.
September 2024 in “Journal of Family Medicine and Primary Care” This study found that primary health physicians in Saudi Arabia generally have low knowledge and practice scores regarding the use of vitamins and minerals for treating hair loss, with no significant difference between more or less experienced doctors.
September 2024 in “Journal of the American Academy of Dermatology” In this study, DataDerm revealed that from 2016 to 2022, a majority of patients diagnosed with keratinocyte carcinoma were male, predominantly white, and commonly between 56-75 years old, with most living in urban areas and having a history of non-melanoma skin cancer.
September 2024 in “Journal of Drugs in Dermatology” This review found that various dermatological procedures for Seborrheic Dermatitis, such as phototherapy and laser treatments, showed significant efficacy in small cohorts with high patient satisfaction, but highlighted the need for further research to standardize protocols and evaluate long-term outcomes.
August 2024 in “PLoS ONE” This study reported that rosemary is widely used among Jordanians for various purposes, such as improving hair condition and addressing gastrointestinal issues, with younger participants showing higher knowledge about its benefits and uses.
July 2024 in “The Journal of Dermatology” This study among patients with severe alopecia areata in South Korea found that 93.4% received pharmacological treatment, with 71.0% achieving hair regrowth and 59.2% experiencing major regrowth, but highlighted a critical unmet need for more effective treatment strategies.
July 2024 in “Journal of Investigative Dermatology” In these two clinical trials, DS-2325a, a KLK5 inhibitor, was found to be generally safe and well tolerated in healthy volunteers, with mild and non-serious adverse events, suggesting its potential for further development as a treatment for Netherton Syndrome.
July 2024 in “International Journal of Women’s Dermatology” This study found that many women who wear the hijab have concerns about alopecia, largely relying on social media for haircare information, which highlights the need for inclusive dermatological guidance.
July 2024 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” This review highlights encouraging findings on platelet-rich plasma's effectiveness in improving skin texture, firmness, and elasticity in aesthetic procedures but emphasizes the need for more standardized protocols and robust clinical trials.
July 2024 in “The Egyptian Journal of Hospital Medicine” In this study of Egyptian patients on hepatitis C treatment, 34% experienced skin-related side effects from sofosbuvir and daclatasvir, such as itching and hyperpigmentation, but most reactions were mild and reversible without needing to stop therapy.
June 2024 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” This study highlights that anabolic steroid use is prevalent among bodybuilders in Sergipe, regardless of socioeconomic background, with many experiencing acute and chronic side effects.
April 2024 in “Assiut Scientific Nursing Journal” In this study, researchers assessed the quality of life in 70 patients with alopecia areata, finding that treatment choice and age positively correlated with quality of life, while factors like sex, education, and knowledge did not.
April 2024 in “DergiPark (Istanbul University)” This study reviewed phototherapy data for pediatric patients over 5 years, finding psoriasis as the most common condition treated. The researchers reported a lower incidence of side effects compared to similar studies but also noted lower treatment response rates.
April 2024 in “Frontiers in pharmacology” This study compared JAK inhibitors for moderate-to-severe alopecia areata and found brepocitinib 30mg and deuruxolitinib 12mg to be most effective, though deuruxolitinib may cause more adverse events. Further research is needed for long-term efficacy and safety.
March 2024 in “Journal of drugs in dermatology” This study evaluated the safety and effectiveness of HASHA, a new hyaluronic acid injectable, for chin augmentation in adults with chin retrusion. HASHA significantly improved chin appearance and satisfaction over 12 months compared to controls, with only mild or moderate transient adverse events.
February 2024 in “Tissue & Cell” This review evaluates recent advancements in hair follicle bioengineering and discusses the potential for developing effective treatments for hair loss through tissue engineering, despite current challenges in creating functional cultured human hair cells.
February 2024 in “Skin health and disease” This source reviews popular cosmeceutical ingredients for skin care, noting that while they are popular among consumers for anti-aging benefits, many lack robust clinical evidence for their efficacy and safety, as they are not regulated by the FDA.
February 2024 in “Mağallaẗ Al-Iqtiṣād Al-Manzilī - Ǧāmiʿaẗ Al-Munūfiyyaẗ” This study reported that Egyptian and Omani men with obesity had similar nutritional and lifestyle factors contributing to their condition, highlighting the importance of diet and physical activity in managing obesity.
January 2024 in “Dermatology practical & conceptual” In this study, researchers evaluated factors influencing alopecia areata recurrence and identified male gender and a family history of the condition as independent predictors for disease recurrence among the 100 patients analyzed.
January 2024 in “bioRxiv (Cold Spring Harbor Laboratory)” This study found that genetic predictions of male pattern baldness derived from European data do not accurately predict baldness in African populations, highlighting significant continental differences in genetic architecture and evolutionary history.
January 2024 in “International Journal of Trichology” This study found that regardless of alopecia type, follicular unit extraction resulted in good patient satisfaction concerning appearance and visual age.
January 2024 in “World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany” Polisorbate 20 is not suitable for curl creams due to instability.
January 2024 in “Dermatology Review” This study assessed the quality of social media information about thread lifting and found it generally low across platforms, with YouTube rated highest. The researchers emphasized the need for dermatologists and plastic surgeons to provide better-quality content and for platforms to monitor health-related information conscientiously.
January 2024 in “Fitoterapia” In this study, the analysis of Ukraine's pharmaceutical market from 2020 to 2023 found a large variety of Vitamin D3 preparations, predominantly domestic and synthetic, with capsule forms being common; consumer surveys highlighted that doctor recommendations strongly influenced purchasing decisions.
January 2024 in “Faculty of 1000 Research Ltd” This study found that aesthetic plastic surgeons in Guangdong, China, show strong interest in continuing education, with varied preferences based on the type of hospital they work in.
December 2023 in “Expert Opinion on Drug Safety” This abstract raises concerns about the safety of finasteride, a medication often used for treating hair loss and prostate issues, due to emerging reports linking it to cognitive dysfunction.
December 2023 in “PubMed” This study reviewed hair loss characteristics in Thai patients post-COVID-19 infection, finding that telogen effluvium commonly occurred 30 days after infection onset, with female gender linked to more severe hair shedding while preexisting androgenetic alopecia was linked to less severe shedding.
December 2023 in “Journal of the American Academy of Dermatology” This study reported that refugee patients referred to dermatology faced significantly longer wait times for consultations compared to the general population, highlighting potential disparities in access to care.
October 2023 in “Revista Medicina Cutánea Ibero-Latino-Americana” In a study conducted on 257 Latin American patients with alopecia areata, researchers found that the most frequent lesion location was the scalp, affecting 86.1% of participants, and reported multiple associated comorbidities, notably cardiovascular and endocrine diseases, with certain conditions being more common in women.
September 2023 in “Dermatology and Therapy” In a Belgian cohort study, nearly 90% of alopecia areata patients treated with oral baricitinib experienced hair regrowth, with more than 70% achieving a favorable SALT score, particularly in patchy cases, though some relapsed post-treatment. No serious adverse events were noted.